Compare LUV & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LUV | VTRS |
|---|---|---|
| Founded | 1967 | 1961 |
| Country | United States | United States |
| Employees | N/A | 30000 |
| Industry | Air Freight/Delivery Services | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.5B | 21.0B |
| IPO Year | 1995 | 2019 |
| Metric | LUV | VTRS |
|---|---|---|
| Price | $46.32 | $20.82 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 26 | 12 |
| Target Price | ★ $50.01 | $21.00 |
| AVG Volume (30 Days) | 6.1M | ★ 8.5M |
| Earning Date | 10-21-2026 | 11-05-2026 |
| Dividend Yield | 1.55% | ★ 2.34% |
| EPS Growth | ★ 3.95 | N/A |
| EPS | ★ 1.47 | N/A |
| Revenue | N/A | ★ $14,299,900,000.00 |
| Revenue This Year | $19.64 | $3.53 |
| Revenue Next Year | $6.88 | $3.69 |
| P/E Ratio | $31.35 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $31.15 | $10.15 |
| 52 Week High | $55.11 | $20.53 |
| Indicator | LUV | VTRS |
|---|---|---|
| Relative Strength Index (RSI) | 62.62 | 73.74 |
| Support Level | $37.33 | $16.02 |
| Resistance Level | $49.93 | N/A |
| Average True Range (ATR) | 1.65 | 0.56 |
| MACD | 0.40 | 0.17 |
| Stochastic Oscillator | 89.65 | 97.87 |
Southwest Airlines is the largest domestic air carrier in the United States by passengers boarded. Southwest operates nearly 800 aircraft in an all-Boeing 737 fleet. Despite offering some longer routes and a few perks for business travelers, the airline predominantly specializes in short-haul, leisure flights operated with a simple cabin configuration in a point-to-point network. In early 2026, Southwest modified its cabins to offer some rows with extra legroom, its ticketing process and merchandising to offer assigned seats, and more fare categories to include a basic economy class that appears for the first time in travel aggregators' search results and more directly competes with other airlines' offerings.
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up one-third of Viatris' total sales. The remaining sales are derived from its portfolio of legacy products, including Lipitor, Norvasc, Lyrica, and Viagra.